• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FTC-133 细胞系中 miR-19a 的过表达诱导更去分化和侵袭的表型。

MiR-19a Overexpression in FTC-133 Cell Line Induces a More De-Differentiated and Aggressive Phenotype.

机构信息

Department of Biomedical and Biotechnological Sciences, Physiology Section, University of Catania, Catania 95123, Italy.

出版信息

Int J Mol Sci. 2018 Dec 7;19(12):3944. doi: 10.3390/ijms19123944.

DOI:10.3390/ijms19123944
PMID:30544640
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6320980/
Abstract

In recent years, microRNAs (miRNAs) have received increasing attention for their important role in tumor initiation and progression. MiRNAs are a class of endogenous small non-coding RNAs that negatively regulate the expression of several oncogenes or tumor suppressor genes. MiR-19a, a component of the oncogenic miR-17-92 cluster, has been reported to be highly expressed only in anaplastic thyroid cancer, the most undifferentiated, aggressive and lethal form of thyroid neoplasia. In this work, we evaluated the putative contribution of miR-19a in de-differentiation and aggressiveness of thyroid tumors. To this aim, we induced miR-19a expression in the well-differentiated follicular thyroid cancer cell line and evaluated proliferation, apoptosis and gene expression profile of cancer cells. Our results showed that miR-19a overexpression stimulates cell proliferation and alters the expression profile of genes related to thyroid cell differentiation and aggressiveness. These findings not only suggest that miR-19a has a possible involvement in de-differentiation and malignancy, but also that it could represent an important prognostic indicator and a good therapeutic target for the most aggressive thyroid cancer.

摘要

近年来,微小 RNA(miRNAs)因其在肿瘤发生和发展中的重要作用而受到越来越多的关注。miRNAs 是一类内源性的小非编码 RNA,可负调控多个癌基因或肿瘤抑制基因的表达。miR-19a 是致癌 miR-17-92 簇的一个组成部分,据报道仅在间变性甲状腺癌中高表达,间变性甲状腺癌是甲状腺肿瘤中最未分化、侵袭性和致命的形式。在这项工作中,我们评估了 miR-19a 在甲状腺肿瘤去分化和侵袭性中的潜在作用。为此,我们在分化良好的滤泡性甲状腺癌细胞系中诱导 miR-19a 的表达,并评估癌细胞的增殖、凋亡和基因表达谱。我们的结果表明,miR-19a 的过表达刺激细胞增殖,并改变与甲状腺细胞分化和侵袭性相关的基因的表达谱。这些发现不仅表明 miR-19a 可能参与去分化和恶性转化,而且还表明它可能成为最具侵袭性甲状腺癌的重要预后指标和良好的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e22/6320980/0c4d430646f8/ijms-19-03944-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e22/6320980/390a4959726c/ijms-19-03944-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e22/6320980/964480a0eae2/ijms-19-03944-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e22/6320980/71395099add9/ijms-19-03944-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e22/6320980/806be25f7858/ijms-19-03944-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e22/6320980/0c4d430646f8/ijms-19-03944-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e22/6320980/390a4959726c/ijms-19-03944-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e22/6320980/964480a0eae2/ijms-19-03944-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e22/6320980/71395099add9/ijms-19-03944-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e22/6320980/806be25f7858/ijms-19-03944-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e22/6320980/0c4d430646f8/ijms-19-03944-g005.jpg

相似文献

1
MiR-19a Overexpression in FTC-133 Cell Line Induces a More De-Differentiated and Aggressive Phenotype.FTC-133 细胞系中 miR-19a 的过表达诱导更去分化和侵袭的表型。
Int J Mol Sci. 2018 Dec 7;19(12):3944. doi: 10.3390/ijms19123944.
2
Thyroid Follicular Cell Loss of Differentiation Induced by MicroRNA miR-17-92 Cluster Is Attenuated by CRISPR/Cas9n Gene Silencing in Anaplastic Thyroid Cancer.微小 RNA miR-17-92 簇诱导的甲状腺滤泡细胞分化丧失可通过 CRISPR/Cas9n 基因沉默在间变性甲状腺癌中减弱。
Thyroid. 2020 Jan;30(1):81-94. doi: 10.1089/thy.2018.0601. Epub 2019 Oct 31.
3
miR-19a Is Involved In Progression And Malignancy Of Anaplastic Thyroid Cancer Cells.miR-19a参与间变性甲状腺癌细胞的进展和恶性转化。
Onco Targets Ther. 2019 Nov 13;12:9571-9583. doi: 10.2147/OTT.S221733. eCollection 2019.
4
Differential miRNA expression defines migration and reduced apoptosis in follicular thyroid carcinomas.差异性miRNA表达决定了滤泡状甲状腺癌的迁移能力及凋亡减少。
Mol Cell Endocrinol. 2014 May 5;388(1-2):1-9. doi: 10.1016/j.mce.2014.02.011. Epub 2014 Mar 12.
5
Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells.miR-17-92簇在间变性甲状腺癌细胞中的致癌作用。
Cancer Sci. 2008 Jun;99(6):1147-54. doi: 10.1111/j.1349-7006.2008.00800.x. Epub 2008 Apr 21.
6
Down-regulation of miR-181b promotes apoptosis by targeting CYLD in thyroid papillary cancer.微小RNA-181b的下调通过靶向去泛素化酶CYLD促进甲状腺乳头状癌细胞凋亡。
Int J Clin Exp Pathol. 2014 Oct 15;7(11):7672-80. eCollection 2014.
7
Antisense-miR-21 enhances differentiation/apoptosis and reduces cancer stemness state on anaplastic thyroid cancer.反义微小RNA-21增强间变性甲状腺癌的分化/凋亡并降低癌症干细胞状态。
Tumour Biol. 2016 Jan;37(1):1299-308. doi: 10.1007/s13277-015-3923-z. Epub 2015 Aug 20.
8
miR-191 down-regulation plays a role in thyroid follicular tumors through CDK6 targeting.miR-191 的下调通过靶向 CDK6 在甲状腺滤泡肿瘤中发挥作用。
J Clin Endocrinol Metab. 2011 Dec;96(12):E1915-24. doi: 10.1210/jc.2011-0408. Epub 2011 Sep 28.
9
A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma.在滤泡性甲状腺癌中,一小部分人类微小RNA的表达失调。
J Clin Endocrinol Metab. 2006 Sep;91(9):3584-91. doi: 10.1210/jc.2006-0693. Epub 2006 Jul 5.
10
Expression of miR-100 and RBSP3 in FTC-133 cells after exposure to 131I.131I 照射后 FTC-133 细胞中 miR-100 和 RBSP3 的表达
Nucl Med Commun. 2014 Sep;35(9):932-8. doi: 10.1097/MNM.0000000000000142.

引用本文的文献

1
Plasma miRNA-146b-3p, -222-3p, -221-5p, -21a-3p Expression Levels and Methylation: Diagnostic Potential and Association with Clinical and Pathological Features in Papillary Thyroid Cancer.血浆 miRNA-146b-3p、-222-3p、-221-5p、-21a-3p 表达水平和甲基化:在甲状腺乳头状癌中的诊断潜力及与临床和病理特征的相关性。
Int J Mol Sci. 2024 Aug 1;25(15):8412. doi: 10.3390/ijms25158412.
2
MicroRNA-mediated metabolic regulation of immune cells in cancer: an updated review.微小 RNA 介导的癌症免疫细胞代谢调控:最新综述。
Front Immunol. 2024 Jun 28;15:1424909. doi: 10.3389/fimmu.2024.1424909. eCollection 2024.
3
Decoding the interaction between miR-19a and CBX7 focusing on the implications for tumor suppression in cancer therapy.

本文引用的文献

1
miRNA and long non-coding RNA: molecular function and clinical value in breast and ovarian cancers.miRNA 和长非编码 RNA:在乳腺癌和卵巢癌中的分子功能和临床价值。
Expert Rev Mol Diagn. 2018 Nov;18(11):963-979. doi: 10.1080/14737159.2018.1538794. Epub 2018 Oct 29.
2
Poorly differentiated carcinoma of thyroid: Case report of an uncommon entity.甲状腺低分化癌:一种罕见实体的病例报告。
J Cancer Res Ther. 2018 Jul-Sep;14(5):1142-1144. doi: 10.4103/0973-1482.187239.
3
The emerging role of miR-19 in glioma.miR-19 在神经胶质瘤中的新兴作用。
解析 miR-19a 与 CBX7 的相互作用,聚焦其对癌症治疗中肿瘤抑制的意义。
Med Oncol. 2023 Dec 19;41(1):21. doi: 10.1007/s12032-023-02251-y.
4
Low-level laser selectively inhibiting colorectal cancer cell metabolic activity and inducing apoptosis for delaying the development of intestinal cancer.低水平激光选择性抑制结直肠癌细胞代谢活性并诱导细胞凋亡,从而延缓肠癌的发展。
Photochem Photobiol Sci. 2023 Jul;22(7):1707-1720. doi: 10.1007/s43630-023-00409-1. Epub 2023 Apr 18.
5
Autophagy-Related MicroRNA: Tumor miR-125b and Thyroid Cancers.自噬相关 microRNA:肿瘤 miR-125b 与甲状腺癌。
Genes (Basel). 2023 Mar 9;14(3):685. doi: 10.3390/genes14030685.
6
Phytochemical Analysis and Anti-Inflammatory and Anti-Osteoarthritic Bioactive Potential of L. (Scrophulariaceae) Leaf Extract Evaluated in Two In Vitro Models of Inflammation and Osteoarthritis.采用两种体外炎症和骨关节炎模型评价 L.(玄参科)叶提取物的植物化学分析及抗炎和抗骨关节炎生物活性潜力。
Molecules. 2021 Sep 5;26(17):5392. doi: 10.3390/molecules26175392.
7
Role of miRNA-19a in Cancer Diagnosis and Poor Prognosis.微小RNA-19a在癌症诊断及预后不良中的作用
Int J Mol Sci. 2021 Apr 29;22(9):4697. doi: 10.3390/ijms22094697.
8
Molecular Markers Guiding Thyroid Cancer Management.指导甲状腺癌治疗的分子标志物
Cancers (Basel). 2020 Aug 4;12(8):2164. doi: 10.3390/cancers12082164.
9
The role of microRNAs in the pathogenesis of thyroid cancer.微小RNA在甲状腺癌发病机制中的作用。
Noncoding RNA Res. 2020 Jun 20;5(3):88-98. doi: 10.1016/j.ncrna.2020.06.001. eCollection 2020 Sep.
10
miR-19a Is Involved In Progression And Malignancy Of Anaplastic Thyroid Cancer Cells.miR-19a参与间变性甲状腺癌细胞的进展和恶性转化。
Onco Targets Ther. 2019 Nov 13;12:9571-9583. doi: 10.2147/OTT.S221733. eCollection 2019.
J Cell Mol Med. 2018 Oct;22(10):4611-4616. doi: 10.1111/jcmm.13788. Epub 2018 Aug 2.
4
MiR-19a negatively regulated the expression of PTEN and promoted the growth of ovarian cancer cells.miR-19a 负向调控 PTEN 的表达,促进卵巢癌细胞的生长。
Gene. 2018 Sep 5;670:166-173. doi: 10.1016/j.gene.2018.05.063. Epub 2018 May 18.
5
MicroRNA-19a and microRNA-19b promote the malignancy of clear cell renal cell carcinoma through targeting the tumor suppressor RhoB.微小RNA-19a和微小RNA-19b通过靶向肿瘤抑制因子RhoB促进透明细胞肾细胞癌的恶性发展。
PLoS One. 2018 Feb 23;13(2):e0192790. doi: 10.1371/journal.pone.0192790. eCollection 2018.
6
MicroRNA-19a acts as a prognostic marker and promotes prostate cancer progression via inhibiting VPS37A expression.微小RNA-19a作为一种预后标志物,通过抑制VPS37A的表达促进前列腺癌进展。
Oncotarget. 2017 Dec 6;9(2):1931-1943. doi: 10.18632/oncotarget.23026. eCollection 2018 Jan 5.
7
MiR-19 regulates the proliferation and invasion of glioma by RUNX3 via β-catenin/Tcf-4 signaling.微小RNA-19通过RUNX3经由β-连环蛋白/Tcf-4信号通路调控胶质瘤的增殖和侵袭。
Oncotarget. 2017 Nov 28;8(67):110785-110796. doi: 10.18632/oncotarget.22720. eCollection 2017 Dec 19.
8
S100A4 in cancer progression and metastasis: A systematic review.S100A4在癌症进展和转移中的作用:一项系统综述。
Oncotarget. 2017 May 19;8(42):73219-73239. doi: 10.18632/oncotarget.18016. eCollection 2017 Sep 22.
9
miR18a and miR19a Recruit Specific Proteins for Splicing in Thyroid Cancer Cells.miR18a和miR19a在甲状腺癌细胞中招募特定蛋白质进行剪接。
Cancer Genomics Proteomics. 2017 Sep-Oct;14(5):373-381. doi: 10.21873/cgp.20047.
10
Prognostic markers in well differentiated papillary and follicular thyroid cancer (WDTC).分化型甲状腺癌(WDTC)的预后标志物。
Eur J Surg Oncol. 2018 Mar;44(3):286-296. doi: 10.1016/j.ejso.2017.07.013. Epub 2017 Aug 3.